Skip to Content

Oxymycine LA (Canada)

This page contains information on Oxymycine LA for veterinary use.
The information provided typically includes the following:
  • Oxymycine LA Indications
  • Warnings and cautions for Oxymycine LA
  • Direction and dosage information for Oxymycine LA

Oxymycine LA

This treatment applies to the following species:
Manufacturer: Zoetis

DIN 02259958

STERILE INJECTABLE SOLUTION

Veterinary Use Only

A long acting broad-spectrum antibiotic.

Contains per mL:

Oxytetracycline (as oxytetracycline dihydrate BP) 200 mg

Description

Oxymycine LA Injectable Solution is specially formulated to provide sustained antibiotic blood levels up to 4 days in cattle and pigs following a single treatment.

Oxymycine LA is a sterile, long acting stable aqueous solution containing oxytetracycline dihydrate equivalent to 200 mg oxytetracycline base per mL.

Advantages:

Oxymycine LA Injectable Solution offers the advantage of combining broad-spectrum effectiveness against both Gram-positive and Gram-negative bacteria, with prolonged antibiotic blood levels up to 4 days duration following a single treatment. Oxymycine LA yields higher blood levels during the first 24 hours and comparable levels up to 48 hours when compared to daily injections of oxytetracycline 100 mg/mL (Oxymycine LP).

Oxymycine LA Indications

Oxymycine LA Injectable Solution is indicated in the treatment of infections caused by oxytetracycline susceptible bacteria in cattle and swine.

Cattle: Bacterial Pneumonia, Pasteurellosis (associated with shipping fever complex), Mastitis, Metritis, Calf Scours (Bacterial Enteritis), Foot Rot, Navel ill, Calf Diphtheria, Leptospirosis, Blackleg/Malignant Edema, Peritonitis, Joint ill.

Swine: Erysipelas, Bacterial Enteritis, Leptospirosis, Metritis, Mastitis, Bacterial Pneumonia.

Dosage and Administration

For administration by intramuscular injection to cattle and swine and subcutaneous injection to cattle only.

Cattle: administer by deep intramuscular injection or subcutaneous injection at a single dose rate of 1 mL per 10 kg of live bodyweight (20 mg oxytetracycline per kg bodyweight).

Swine: administer by deep intramuscular injection at a single dose rate of 1 mL per 10 kg of live bodyweight (20 mg oxytetracycline per kg bodyweight).

It is recommended that the maximum dose at any one site is 10 mL in cattle and 5 mL in pigs in order to minimise local tissue irritation at the injection site. Intramuscular injections should be made deep into the fleshy part of the muscle such as the thigh or neck region. Following administration, temporary localised swelling may be observed at the site of injection for several days. This is due to the high concentration and long acting effect of the product.

Oxymycine LA Injectable Solution should be warmed to body temperature prior to administration.

If clinical improvement is not observed after 48 hours, clinical re-evaluation may be required. In non-responsive cases, consideration may be given to the use of an alternative antibiotic.

Note:

Treatment with Oxymycine LA Injectable Solution only, in severe disease cases, may be insufficient.

Warning

Intramuscular administration: Treated cattle and swine must not be slaughtered for use in food for at least 21 days after the latest treatment with this drug.

Subcutaneous administration: Treated cattle must not be slaughtered for use in food for at least 42 days after the latest treatment with this drug.

Do not use in lactating dairy cattle.

Note:

To avoid the possibility of excessive trim at the site of injection, do not slaughter cattle for at least 42 days after the latest treatment with this drug.

Cautions:

Occasional hypersensitivity reactions (anaphylaxis) have been observed following the parenteral administration of oxytetracycline. If such side effects occur, discontinue use of the drug and administer epinephrine immediately.

The safety of this product in pregnant animals has not been demonstrated.

Storage

Store below 25°C and protect from light. Do not freeze.

Presentation:

Oxymycine LA Injectable Solution is available in multidose 250 mL and 500 mL vials.

Zoetis is a trademark of Zoetis or its licensors, used under license by Zoetis Canada Inc.

Zoetis Canada Inc., Kirkland QC H9H 4M7

Net

 

500 mL

2653-09-0

CPN: 1198392.3

ZOETIS CANADA INC.
16,740 TRANS-CANADA HIGHWAY, KIRKLAND, QC, H9H 4M7
Order Desk:   800-663-8888
Technical Services Canada:   800-461-0917
Technical Services USA:   800-366-5288
Website:   www.zoetis.ca
Every effort has been made to ensure the accuracy of the Oxymycine LA information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-10-31

Hide